For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231101:nRSA9263Ra&default-theme=true
RNS Number : 9263R Cambridge Cognition Holdings PLC 01 November 2023
1 November 2023
Cambridge Cognition Holdings plc
("Cambridge Cognition", the "Company" or the "Group")
Total Voting Rights
Cambridge Cognition (AIM: COG), which develops and markets digital solutions
to assess brain health, announces that pursuant to its block admission
facility, details of which were announced on 21 March 2023, it has recently
issued 82,092 new ordinary shares in the Company in satisfaction of the
exercise of employee share options. Accordingly, as at 31 October 2023 the
Company has 34,934,925 ordinary shares in issue.
There are no shares held in treasury therefore the total number of voting
rights in the Company is 34,934,925. This figure may be used by shareholders
as the denominator for the calculation by which they will determine if they
are required to notify their interest in, or a change to their interest in
Cambridge Cognition under the FCA's Disclosure and Transparency Rules.
Enquiries:
Cambridge Cognition Holdings Plc Tel: 012 2381 0700
Matthew Stork, Chief Executive Officer press@camcog.com (mailto:press@camcog.com)
Stephen Symonds, Chief Financial Officer
Panmure Gordon (UK) Limited (NOMAD and Joint Broker) Tel: 020 7886 2968
Freddy Crossley / Emma Earl (Corporate Finance)
Rupert Dearden (Corporate Broking)
Dowgate Capital Limited (Joint Broker) Tel: 020 3903 7715
David Poutney / James Serjeant
IFC Advisory Ltd (Financial PR and IR) Tel: 020 3934 6630
Tim Metcalfe / Graham Herring / Zach Cohen
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVRWPGPGUUPWGMG